Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (69)

2024

  1. Author Correction: Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma (Scientific Reports, (2024), 14, 1, (4561), 10.1038/s41598-024-55287-z)

    Scientific Reports

  2. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

    Journal of Hepatology

  3. Corrigendum to “Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel” [Autoimmunity Reviews, Volume 22, Issue 12, December 2023, 103479] (Autoimmunity Reviews (2023) 22(12), (S1568997223002136), (10.1016/j.autrev.2023.103479))

    Autoimmunity Reviews

  4. Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma

    Scientific Reports, Vol. 14, Núm. 1

  5. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

  6. Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©

    Ophthalmology and Therapy, Vol. 13, Núm. 6, pp. 1669-1682

  7. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  8. T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)

    Journal of Pediatrics, Vol. 272

  9. XEN® 45 en el manejo quirúrgico del glaucoma en fases tempranas: estudio nacional de consenso según metodología Delphi

    Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 3, pp. 98-108

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

  3. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  4. European Glaucoma Society - A guide on surgical innovation for glaucoma

    British Journal of Ophthalmology, Vol. 107, Núm. Suppl 1, pp. 1-114

  5. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

    Frontiers in immunology, Vol. 14, pp. 1185517

  6. Folliculitis Decalvans Has a Heterogeneous Microbiological Signature and Impaired Immunological Response

    Dermatology, Vol. 239, Núm. 3, pp. 454-461

  7. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming

    Journal of Hepatology, Vol. 79, Núm. 3, pp. 728-740

  8. Impacto presupuestario de XEN®63 en el tratamiento del glaucoma primario de ángulo abierto en España

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 1, pp. 2-10

  9. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

  10. Progresión en glaucoma. Guía de práctica clínica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 1, pp. 40-57

  11. Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel

    Autoimmunity Reviews, Vol. 22, Núm. 12